Strategies to minimize variability and bias associated with manual pipetting in ligand binding assays to assure data quality of protein therapeutic quantification.
about
Toward sensitive and accurate analysis of antibody biotherapeutics by liquid chromatography coupled with mass spectrometry.Ligand binding assays in the 21st Century laboratory: automation.Specific method validation and sample analysis approaches for biocomparability studies of denosumab addressing method and manufacture site changesMethod transfer for ligand-binding assays: recommendations for best practice.Automate it: ligand-binding assay productivity in a discovery bioanalytical setting.Mitigation of microtiter plate positioning effects using a block randomization scheme.Laboratory automation of high-quality and efficient ligand-binding assays for biotherapeutic drug development.Bioanalytical considerations in the comparability assessment of biotherapeutics.A generic template for automated bioanalytical ligand-binding assays using modular robotic scripts in support of discovery biotherapeutic programs.Automating bioanalytical sample analysis through enhanced system integration.Discovery fit-for-purpose ligand-binding PK assays: what's really important?Serum sample stability in ligand-binding assays: challenges in assessments of long-term, bench-top and multiple freeze-thaw.Validation and life-cycle management of a quantitative ligand-binding assay for the measurement of Nulojix(®), a CTLA-4-Fc fusion protein, in renal and liver transplant patients.
P2860
Q34359998-38C3CE9E-9142-4A3A-9F17-BB5A498987EEQ35793118-6C7DC566-F068-4E82-8380-9B1FEDF4D51EQ36502429-C1198C98-C036-47B7-9084-ACCBC3F7F3F5Q37937607-B9D4C455-C3CB-4F11-8411-88A23F8D781FQ38122197-8E34AB6F-5E22-4C8D-9266-E1B73223980DQ39820417-874DD3F3-1EAF-4CEF-9DB7-FA6F6A3324ECQ42607030-53C2BAE4-BCE1-4956-AB3B-2F74FE1163E2Q44701500-EAEC8447-DF5F-431F-B0B5-DD0FC1C7E207Q44767432-AB5DBDF6-3169-47C8-97BA-311BFF0C427CQ45790959-562DF3B6-AD90-4919-9ED0-1857967A3CF6Q45840475-A667A4AF-E629-497D-8504-09001E34FEF5Q46705457-EDAF5C02-C3BA-4ACF-BF7F-A5FF0A8D9E39Q53100427-61570907-AE88-43F2-B93E-F2DC9D7FA690
P2860
Strategies to minimize variability and bias associated with manual pipetting in ligand binding assays to assure data quality of protein therapeutic quantification.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Strategies to minimize variabi ...... in therapeutic quantification.
@ast
Strategies to minimize variabi ...... in therapeutic quantification.
@en
Strategies to minimize variabi ...... in therapeutic quantification.
@nl
type
label
Strategies to minimize variabi ...... in therapeutic quantification.
@ast
Strategies to minimize variabi ...... in therapeutic quantification.
@en
Strategies to minimize variabi ...... in therapeutic quantification.
@nl
prefLabel
Strategies to minimize variabi ...... in therapeutic quantification.
@ast
Strategies to minimize variabi ...... in therapeutic quantification.
@en
Strategies to minimize variabi ...... in therapeutic quantification.
@nl
P2093
P921
P1476
Strategies to minimize variabi ...... in therapeutic quantification.
@en
P2093
Binodh DeSilva
Chad A Ray
Jean W Lee
Kinnari Pandya
Laura Brunner
P304
P356
10.1016/J.JPBA.2010.04.025
P577
2010-04-28T00:00:00Z